HFS
SYRE icon

Hughes Financial Services’s Spyre Therapeutics SYRE Stock Holding History

Hughes Financial Services’s Portfolio SYRE Stock Details SYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$355 Buy
+4
New +$292 ﹤0.01% 1167

Other funds holding SYRE

HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
EA
Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Hughes Financial Services's SYRE Position: Q2 2026 in Review

Hughes Financial Services opened a new position in Spyre Therapeutics (SYRE) in Q2 2026: 4 shares worth $355. The stake represents ﹤0.01% of the portfolio and ranks #1167 among its holdings.

19 funds tracked by Wall St. Rank hold SYRE as of Q2 2026.

  • Hughes Financial Services held 4 shares of Spyre Therapeutics worth $355 as of Q2 2026.
  • Spyre Therapeutics was a new Hughes Financial Services position in Q2 2026.
  • Spyre Therapeutics made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #1167 holding.
  • 19 funds tracked by Wall St. Rank held Spyre Therapeutics as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.